Hosted on MSN3mon
Beyfortus RSV treatment to launch in Korea next month
Yun Ki-wook, a professor in SNUH's Department of Pediatric Infectious Diseases, discusses the domestic release of Beyfortus, an antibody treatment for respiratory syncytial virus, during a press ...
pharmaphorum1y
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
AstraZeneca and Sanofi’s long-acting antibody Beyfortus has been approved in China for the prevention of respiratory syncytial virus (RSV) infections in newborns and infants, opening up a major ...
pharmaphorum1y
Beyfortus cleared by FDA for RSV prevention in infants
Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV disease in infants.
Hosted on MSN10mon
Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
Roughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new preventive medicine nirsevimab, Public Health France said on Friday. The health agency cited two studies ...